These authors contributed equally to this study.
In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy
Version of Record online: 16 MAR 2010
Copyright © 2010 John Wiley & Sons, Ltd.
The Journal of Gene Medicine
Volume 12, Issue 4, pages 354–364, April 2010
How to Cite
Wang, Q., Yin, H., Camelliti, P., Betts, C., Moulton, H., Lee, H., Saleh, A. F., Gait, M. J. and Wood, M. J. A. (2010), In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy. J. Gene Med., 12: 354–364. doi: 10.1002/jgm.1446
- Issue online: 29 MAR 2010
- Version of Record online: 16 MAR 2010
- Manuscript Accepted: 14 FEB 2010
- Manuscript Revised: 22 DEC 2009
- Manuscript Received: 12 AUG 2009
- Action Duchenne UK
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.